Cited 12 times in
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.